319 related articles for article (PubMed ID: 12617722)
21. Sp1 transcription factor as a molecular target for nitric oxide-- and cyclic nucleotide--mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells.
Sellak H; Yang X; Cao X; Cornwell T; Soff GA; Lincoln T
Circ Res; 2002 Mar; 90(4):405-12. PubMed ID: 11884369
[TBL] [Abstract][Full Text] [Related]
22. An N-terminally truncated form of cyclic GMP-dependent protein kinase Iα (PKG Iα) is monomeric and autoinhibited and provides a model for activation.
Moon TM; Sheehe JL; Nukareddy P; Nausch LW; Wohlfahrt J; Matthews DE; Blumenthal DK; Dostmann WR
J Biol Chem; 2018 May; 293(21):7916-7929. PubMed ID: 29602907
[TBL] [Abstract][Full Text] [Related]
23. Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation.
Turko IV; Francis SH; Corbin JD
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):505-10. PubMed ID: 9445376
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cGMP-dependent protein kinase by the regulatory subunit of photoreceptor cGMP phosphodiesterase.
Guo LW; Ruoho AE
Neurosci Lett; 2006 Jul; 401(3):252-5. PubMed ID: 16603314
[TBL] [Abstract][Full Text] [Related]
25. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
Wyatt TA; Naftilan AJ; Francis SH; Corbin JD
Am J Physiol; 1998 Feb; 274(2):H448-55. PubMed ID: 9486247
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity.
Francis SH; Bessay EP; Kotera J; Grimes KA; Liu L; Thompson WJ; Corbin JD
J Biol Chem; 2002 Dec; 277(49):47581-7. PubMed ID: 12359732
[TBL] [Abstract][Full Text] [Related]
27. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
Ren Y; Zheng J; Yao X; Weng G; Wu L
Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
[TBL] [Abstract][Full Text] [Related]
28. Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5).
Fink TL; Francis SH; Beasley A; Grimes KA; Corbin JD
J Biol Chem; 1999 Dec; 274(49):34613-20. PubMed ID: 10574925
[TBL] [Abstract][Full Text] [Related]
29. Hydrogen peroxide enhances vasodilatation by increasing dimerization of cGMP-dependent protein kinase type Iα.
Dou D; Zheng X; Liu J; Xu X; Ye L; Gao Y
Circ J; 2012; 76(7):1792-8. PubMed ID: 22498562
[TBL] [Abstract][Full Text] [Related]
30. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
Turko IV; Francis SH; Corbin JD
Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742
[TBL] [Abstract][Full Text] [Related]
31. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
Rybalkin SD; Rybalkina IG; Feil R; Hofmann F; Beavo JA
J Biol Chem; 2002 Feb; 277(5):3310-7. PubMed ID: 11723116
[TBL] [Abstract][Full Text] [Related]
33. Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Iα Oxidation.
Prysyazhna O; Burgoyne JR; Scotcher J; Grover S; Kass D; Eaton P
J Biol Chem; 2016 Aug; 291(33):17427-36. PubMed ID: 27342776
[TBL] [Abstract][Full Text] [Related]
34. cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain.
Alverdi V; Mazon H; Versluis C; Hemrika W; Esposito G; van den Heuvel R; Scholten A; Heck AJ
J Mol Biol; 2008 Feb; 375(5):1380-93. PubMed ID: 18082764
[TBL] [Abstract][Full Text] [Related]
35. The catalytic domain of the cGMP-dependent protein kinase Ialpha modulates the cGMP-binding characteristics of its regulatory domain.
Dostmann WR; Koep N; Endres R
FEBS Lett; 1996 Dec; 398(2-3):206-10. PubMed ID: 8977108
[TBL] [Abstract][Full Text] [Related]
36. An auto-inhibited state of protein kinase G and implications for selective activation.
Sharma R; Kim JJ; Qin L; Henning P; Akimoto M; VanSchouwen B; Kaur G; Sankaran B; MacKenzie KR; Melacini G; Casteel DE; Herberg FW; Kim C
Elife; 2022 Aug; 11():. PubMed ID: 35929723
[TBL] [Abstract][Full Text] [Related]
37. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA
EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648
[TBL] [Abstract][Full Text] [Related]
38. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
39. Conformational conversion of PDE5 by incubation with sildenafil or metal ion is accompanied by stimulation of allosteric cGMP binding.
Corbin JD; Francis SH
Cell Signal; 2011 Oct; 23(10):1578-83. PubMed ID: 21620965
[TBL] [Abstract][Full Text] [Related]
40. Expression and function of cGMP-dependent protein kinase type I during medaka fish embryogenesis.
Yamamoto T; Suzuki N
J Biol Chem; 2005 Apr; 280(17):16979-86. PubMed ID: 15710621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
